Skip to main content
Alkem Laboratories Limited (NSE:ALKEM)
India flag India · Delayed Price · Currency is INR
5,460.00
-70.00 (-1.27%)
Mar 9, 2026, 3:29 PM IST

Alkem Laboratories Revenue

Alkem Laboratories had revenue of 37.37B INR in the quarter ending December 31, 2025, with 10.74% growth. This brings the company's revenue in the last twelve months to 142.53B, up 11.73% year-over-year. In the fiscal year ending March 31, 2025, Alkem Laboratories had annual revenue of 129.65B with 2.34% growth.

Revenue (ttm)
142.53B
Revenue Growth
+11.73%
P/S Ratio
4.64
Revenue / Employee
7.59M
Employees
18,785
Market Cap
661.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025129.65B2.97B2.34%
Mar 31, 2024126.68B10.68B9.21%
Mar 31, 2023115.99B9.65B9.08%
Mar 31, 2022106.34B17.69B19.96%
Mar 31, 202188.65B5.21B6.24%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aurobindo Pharma 331.82B
Glenmark Pharmaceuticals 165.10B
Laurus Labs 67.22B
Mankind Pharma 139.14B
Zydus Lifesciences 260.89B
Cipla 279.67B
Ipca Laboratories 95.06B
Ajanta Pharma 52.02B
Revenue Rankings

Alkem Laboratories News

More News